- Home
- SHOT vs RPID Comparison
SHOT vs RPID Comparison
Compare SHOT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- RPID
- Stock Information
- Founded
- SHOT 2018
- RPID 2006
- Country
- SHOT United States
- RPID United States
- Employees
- SHOT N/A
- RPID N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- RPID Medical Specialities
- Sector
- SHOT Health Care
- RPID Health Care
- Exchange
- SHOT Nasdaq
- RPID Nasdaq
- Market Cap
- SHOT 137.3M
- RPID 138.9M
- IPO Year
- SHOT 2020
- RPID 2021
- Fundamental
- Price
- SHOT $0.65
- RPID $2.62
- Analyst Decision
- SHOT
- RPID Strong Buy
- Analyst Count
- SHOT 0
- RPID 2
- Target Price
- SHOT N/A
- RPID $8.00
- AVG Volume (30 Days)
- SHOT 12.3M
- RPID 130.9K
- Earning Date
- SHOT 08-26-2025
- RPID 08-12-2025
- Dividend Yield
- SHOT N/A
- RPID N/A
- EPS Growth
- SHOT N/A
- RPID N/A
- EPS
- SHOT N/A
- RPID N/A
- Revenue
- SHOT N/A
- RPID $30,289,000.00
- Revenue This Year
- SHOT N/A
- RPID $17.94
- Revenue Next Year
- SHOT N/A
- RPID $20.55
- P/E Ratio
- SHOT N/A
- RPID N/A
- Revenue Growth
- SHOT 246.36
- RPID 22.57
- 52 Week Low
- SHOT $0.23
- RPID $0.80
- 52 Week High
- SHOT $1.77
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- SHOT 48.12
- RPID 33.86
- Support Level
- SHOT $0.39
- RPID $2.40
- Resistance Level
- SHOT $0.69
- RPID $3.59
- Average True Range (ATR)
- SHOT 0.21
- RPID 0.38
- MACD
- SHOT -0.05
- RPID -0.11
- Stochastic Oscillator
- SHOT 27.19
- RPID 11.74
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.